Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Instructions for Submission of Clinical Information

Manufacturers whose products are being reviewed may submit clinical information to the Drugs and Therapeutics (D and T) Advisory Board and the Department. Manufacturers should submit a concise synopsis of their product.  This synopsis should be no more than four pages in length.  The Board is particularly interested in information that sets a drug apart from other drugs in its class or PDL category.  The Board is not interested in materials intended to market a product.  For information on the process for submitting clinical information to the D and T Advisory Board, manufacturers should contact Department Board Liaison at: HFS.DandTAdvisoryBoard@illinois.gov. Clinical information may also be submitted to the department’s board liaison at:

D&T Advisory Board
Attn: Board Liaison
607 East Adams Street, 4th Floor
Springfield, IL 62701
HFS.DandTAdvisoryBoard@illinois.gov
217-524-7112

Clinical Submissions may also be sent to the Department’s clinical Contractor at:

Mary Lynn Moody, BSPharm
Director, Drug Information Center
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois at Chicago
College of Pharmacy
833 S. Wood Street
Chicago, Il 60611
312-996-2351
mlmoody@uic.edu